MedPath

Comparison of inhalation techniques in children with asthma using metered dose inhaler and spacer

Completed
Conditions
Bronchial asthma
Registration Number
CTRI/2013/04/003559
Lead Sponsor
Divya Anna Stephen
Brief Summary

The study is a randomised control trial comparing the effectiveness of single maximal inhalation versus five tidal breaths for inhalation of salbutamol delivered by metered dose inhaler and spacer in children with asthma. The trial will be conducted at a single site in India. The primary outcome of the study is peak expiratory flow rate  prior to administration of salbutamol with metered dose inhaler and half an hour after administration of salbutamol with metered dose inhaler either by five tidal breathing method or single maximal inhalation with a breath hold method.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria
  • 1.Children with asthma a)Using metered dose inhaler.
  • b)Who are of age 5-15 yrs.
  • c)Whose parent’s give consent to participate in the study.
  • 2.Children who are able to perform the manoeuvre for measuring PEFR.
  • 3.Children who are able to perform breath holding.
Exclusion Criteria
  • 1.Children with a)Acute exacerbations of asthma.
  • b)Chest malformation, congenital abnormalities of the chest.
  • c)Any other cardiovascular or neuromuscular disease.
  • d)Anthropometric parameters less than 3rd percentile.
  • 2.Children receiving regular long acting beta-2 agonist (salmetrol, formetrol).
  • 3.Children who have received beta2 agonist, 6 hrs prior to the observation (salbutamol).
  • 4.Children who have received methylxanthines and anti cholinergic drugs prior to observation (Ipratropium bromide,Theophylline).
  • 5.Children who are already performing single maximal inhalation with a breath hold.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Peak expiratory flow rateO1-Immediately prior to intervention. | O2-Half an after intervention.
Secondary Outcome Measures
NameTimeMethod
Breath hold time duration in single maximal inhalation with a breath hold groupNot applicable

Trial Locations

Locations (1)

AIIMS

🇮🇳

Delhi, DELHI, India

AIIMS
🇮🇳Delhi, DELHI, India
Divya Anna Stephen
Principal investigator
08826052084
divstephen@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.